{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alkaloids", "Cutaneous leishmaniasis", "Glucantime", "Leishmania tropica", "Medicinal plants", "Peganum harmala"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33184551", "DateRevised": {"Year": "2021", "Month": "12", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "09", "Day": "27"}], "Language": ["eng"], "ELocationID": ["10.1007/s12639-020-01232-6"], "Journal": {"ISSN": "0971-7196", "JournalIssue": {"Volume": "44", "Issue": "4", "PubDate": {"Year": "2020", "Month": "Dec"}}, "Title": "Journal of parasitic diseases : official organ of the Indian Society for Parasitology", "ISOAbbreviation": "J Parasit Dis"}, "ArticleTitle": "Evaluation of the effect of <i>Peganum harmala</i> extracts on the in vitro viability of <i>Leishmania tropica</i> promastigotes in comparison to Glucantime.", "Pagination": {"StartPage": "858", "EndPage": "863", "MedlinePgn": "858-863"}, "Abstract": {"AbstractText": ["Cutaneous leishmaniasis is a skin disease that pretends with skin lesions, mainly ulcers, on exposed parts of the body. It's caused mainly by parasites belonging to the genus <i>Leishmania</i>, such as <i>L. tropica.</i> Medicinal plants, which have sparked recent researches attention, consider one of the richest sources of active compounds against the <i>Leishmania</i> parasite including <i>Peganum harmala</i>. This study was conducted to investigate the antileishmanial effect of different extracts of <i>Peganum harmala</i> grown in Syria, particularly the methanolic extract of seeds and roots as well as its alkaloid fractions on <i>Leishmania tropica</i> promastigotes growth in vitro. After culturing promastigotes and incubating with extracts for 72\u00a0h, the surviving promastigotes were counted. The half maximal (50%) inhibitory concentration (IC<sub>50</sub>) was determined. The experiments were repeated at least three times. The in vitro experiment has demonstrated a concentration-dependent decrease of parasites number caused by the extracts with an IC<sub>50</sub> value of 18.61\u2009\u00b1\u20090.87\u00a0\u00b5g/mL and 16.41\u2009\u00b1\u20090.71\u00a0\u00b5g/mL for the methanolic extract of seeds and roots respectively. While the IC<sub>50</sub> of the alkaloid fractions of seeds and roots were 4.97\u2009\u00b1\u20090.43\u00a0\u03bcg/mL and 9.23\u2009\u00b1\u20090.86\u00a0\u03bcg/mL respectively. There was a significant difference between all extracts and Glucantime which had IC<sub>50</sub>\u2009=\u200932.62\u2009\u00b1\u20090.66\u00a0\u00b5g/mL."], "CopyrightInformation": "\u00a9 Indian Society for Parasitology 2020."}, "AuthorList": [{"Identifier": ["0000-0002-4265-0656"], "AffiliationInfo": [{"Identifier": ["grid.8192.2", "0000 0001 2353 3326"], "Affiliation": "Department of Pharmacognosy, Damascus University, Damascus, Syria."}], "LastName": "Madah", "ForeName": "Manar", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.8192.2", "0000 0001 2353 3326"], "Affiliation": "Department of Biochemistry and Microbiology, Damascus University, Damascus, Syria."}], "LastName": "Haddad", "ForeName": "Shaden", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.8192.2", "0000 0001 2353 3326"], "Affiliation": "Department of Pharmacognosy, Damascus University, Damascus, Syria."}], "LastName": "Khazem", "ForeName": "Mays", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "India", "MedlineTA": "J Parasit Dis", "NlmUniqueID": "9713059", "ISSNLinking": "0971-7196"}, "CoiStatement": "Conflict of interestThe authors declare that they have no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Asgarpanah J, Ramezanloo F. Chemistry, pharmacology and medicinal properties of Peganum harmala L. Afr J Pharm Pharmacol. 2012;6(22):1573\u20131580. doi: 10.5897/ajpp11.876.", "ArticleIdList": ["10.5897/ajpp11.876"]}, {"Citation": "Brobst A, Lewis J, Klett B, Haustein C, Shriver J. The free base extraction of harmaline from Penganum harmala. Am J Undergrad Res. 2009;8:2\u20133. doi: 10.33697/ajur.2009.013.", "ArticleIdList": ["10.33697/ajur.2009.013"]}, {"Citation": "Das BB, Ganguly A, Majumder HK. DNA topoisomerases of Leishmania: the potential targets for anti-leishmanial therapy. In: Majumder HK, editor. Drug targets in Kinetoplastid parasites. New York: Springer Science and Business Media; 2008. pp. 103\u2013115.", "ArticleIdList": ["18365662"]}, {"Citation": "Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004;27(5):305\u2013318. doi: 10.1016/j.cimid.2004.03.004.", "ArticleIdList": ["10.1016/j.cimid.2004.03.004", "15225981"]}, {"Citation": "Di Giorgio C, Delmas F, Ollivier E, Elias R, Balansard G, Timon-David P. In vitro activity of the \u03b2-carboline alkaloids harmane, harmine, and harmaline toward parasites of the species Leishmania infantum. Exp Parasitol. 2004;106(3\u20134):67\u201374. doi: 10.1016/j.exppara.2004.04.002.", "ArticleIdList": ["10.1016/j.exppara.2004.04.002", "15172213"]}, {"Citation": "Fadhil S, Reza MH, Rouhollah G, Reza VRM. Spectrophotometric determination of total alkaloids in Peganum harmala L. using bromocresol green. Res J Phytochem. 2007;1(2):79\u201382. doi: 10.3923/rjphyto.2007.79.82.", "ArticleIdList": ["10.3923/rjphyto.2007.79.82"]}, {"Citation": "Farouk L, Laroubi A, Aboufatima R, Benharref A, Chait A. Evaluation of the analgesic effect of alkaloid extract of Peganum harmala L.: possible mechanisms involved. J Ethnopharmacol. 2008;115(3):449\u2013454. doi: 10.1016/j.jep.2007.10.014.", "ArticleIdList": ["10.1016/j.jep.2007.10.014", "18054186"]}, {"Citation": "Feily A, Saki J, Maraghi S, Moosavi Z, Khademvatan S, Siahpoosh A. In vitro activity of green tea extract against Leishmania major promastigotes. Int J Clin Pharmacol Ther. 2012;50(3):233\u2013236. doi: 10.5414/CP201571.", "ArticleIdList": ["10.5414/CP201571", "22373836"]}, {"Citation": "Ghorbani M, Farhoudi R. Leishmaniasis in humans: drug or vaccine therapy? Drug Des Devel Ther. 2018;12:25. doi: 10.2147/DDDT.S146521.", "ArticleIdList": ["10.2147/DDDT.S146521", "PMC5743117", "29317800"]}, {"Citation": "Hayani K, Dandashli A, Weisshaar E. Cutaneous leishmaniasis in Syria: clinical features, current status and the effects of war. Acta Derm Venereol. 2015;95(1):62\u201366. doi: 10.2340/00015555-1988.", "ArticleIdList": ["10.2340/00015555-1988", "25342106"]}, {"Citation": "Herraiz T, Gonz\u00e1lez D, Anc\u00edn-Azpilicueta C, Ar\u00e1n VJ, Guill\u00e9n H. \u03b2-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO) Food Chem Toxicol. 2010;48(3):839\u2013845. doi: 10.1016/j.fct.009.12.019.", "ArticleIdList": ["10.1016/j.fct.009.12.019", "20036304"]}, {"Citation": "Herraiz T, Guill\u00e9n H, Ar\u00e1n VJ, Salgado A. Identification, occurrence and activity of quinazoline alkaloids in Peganum harmala. Food Chem Toxicol. 2017;103:261\u2013269. doi: 10.1016/j.fct.2017.03.010.", "ArticleIdList": ["10.1016/j.fct.2017.03.010", "28279698"]}, {"Citation": "Khaliq T, Misra P, Gupta S, Reddy KP, Kant R, Maulik PR, Narender T. Peganine hydrochloride dihydrate an orally active antileishmanial agent. Bioorg Med Chem Lett. 2009;19(9):2585\u20132586. doi: 10.1016/j.bmcl.2009.03.039.", "ArticleIdList": ["10.1016/j.bmcl.2009.03.039", "19339182"]}, {"Citation": "Khan FA, Maalik A, Iqbal Z, Malik I. Recent pharmacological developments in \u03b2-carboline alkaloid \u201charmaline\u201d. Eur J Pharmacol. 2013;721(1\u20133):391\u2013394. doi: 10.1016/j.ejphar.2013.05.003.", "ArticleIdList": ["10.1016/j.ejphar.2013.05.003", "23707188"]}, {"Citation": "Li S, Cheng X, Wang C. A review on traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the genus Peganum. J Ethnopharmacol. 2017;203:127\u2013162. doi: 10.1016/j.jep.2017.03.049.", "ArticleIdList": ["10.1016/j.jep.2017.03.049", "28359849"]}, {"Citation": "Maleki F, Zarebavani M, Mohebali M, Dayer MS, Hajialiani F, Tabatabaie F. In vitro and in vivo susceptibility of Leishmania major to some medicinal plants. Asian Pac J Trop Biomed. 2017;7(1):37\u201342. doi: 10.1016/j.apjtb.2016.11.008.", "ArticleIdList": ["10.1016/j.apjtb.2016.11.008"]}, {"Citation": "Mirzaie M, Nosratabadi SJ, Derakhshanfar A, Sharif I. Antileishmanial activity of Peganum harmala extract on the in vitro growth of Leishmania major promastigotes in comparison to a trivalent antimony drug. Vet Arh. 2007;77(4):365."}, {"Citation": "Mishra BB, Kale RR, Singh RK, Tiwari VK. Alkaloids: future prospective to combat leishmaniasis. Fitoterapia. 2009;80(2):81\u201390. doi: 10.1016/j.fitote.2008.10.009.", "ArticleIdList": ["10.1016/j.fitote.2008.10.009", "19015012"]}, {"Citation": "Misra P, Khaliq T, Dixit A, SenGupta S, Samant M, Kumari S, Narender T. Antileishmanial activity mediated by apoptosis and structure-based target study of peganine hydrochloride dihydrate: an approach for rational drug design. J Antimicrob Chemother. 2008;62(5):998\u20131002. doi: 10.1093/jac/dkn319.", "ArticleIdList": ["10.1093/jac/dkn319", "18694906"]}, {"Citation": "Rahimi-Moghaddam P, Ebrahimi SA, Ourmazdi H, Selseleh M, Karjalian M, Haj-Hassani G, Shafiei M (2011) In vitro and in vivo activities of Peganum harmala extract against Leishmania major. J Res Med Sci. 16(8): 1032. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263080/.", "ArticleIdList": ["PMC3263080", "22279479"]}, {"Citation": "Rehman K, Walochnik J, Mischlinger J, Alassil B, Allan R, Ramharter M. Leishmaniasis in northern Syria during civil war. Emerg Infect Dis. 2018;24(11):1973. doi: 10.3201/eid2411.172146.", "ArticleIdList": ["10.3201/eid2411.172146", "PMC6199995", "30334717"]}, {"Citation": "Sobhani AM, Ebrahimi SA, Mahmoudian M. An in vitro evaluation of human DNA topoisomerase I inhibition by Peganum harmala L. seeds extract and its beta-carboline alkaloids. J Pharm Pharm Sci. 2002;5(1):19\u201323.", "ArticleIdList": ["12042115"]}, {"Citation": "Sundar S, Chakravarty J. An update on pharmacotherapy for leishmaniasis. Expert Opin Pharmacother. 2015;16(2):237\u2013252. doi: 10.1517/14656566.2015.973850.", "ArticleIdList": ["10.1517/14656566.2015.973850", "PMC4293334", "25346016"]}, {"Citation": "WHO (2019a) Fact sheet, leishmaniasis, https://www.who.int/news-room/factsheets/detail/leishmaniasis. Accessed 30 Jul 2019"}, {"Citation": "WHO (2019b) Neglected tropical diseases. https://www.emro.who.int/neglected-tropical-diseases/countries/cl-syria.html. Accessed 30 Jul 2019"}, {"Citation": "Zhang G, Chi X. The complete chloroplast genome of Peganum harmala. Mitochondrial DNA Part B. 2019;4(1):1784\u20131785. doi: 10.1080/23802359.2019.1612289.", "ArticleIdList": ["10.1080/23802359.2019.1612289"]}], "ReferenceList": []}], "History": [{"Year": "2019", "Month": "12", "Day": "29"}, {"Year": "2020", "Month": "6", "Day": "1"}, {"Year": "2020", "Month": "11", "Day": "13", "Hour": "5", "Minute": "52"}, {"Year": "2020", "Month": "11", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "11", "Day": "14", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "12", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33184551", "PMC7596110", "10.1007/s12639-020-01232-6", "1232"]}}], "PubmedBookArticle": []}